0000905148-24-001682.txt : 20240607
0000905148-24-001682.hdr.sgml : 20240607
20240607161222
ACCESSION NUMBER: 0000905148-24-001682
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240606
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Collins Helen Louise
CENTRAL INDEX KEY: 0001701247
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41008
FILM NUMBER: 241029507
MAIL ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IO Biotech, Inc.
CENTRAL INDEX KEY: 0001865494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 870909276
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: OLE MAALOES VEH 3
CITY: COPENHAGEN
STATE: G7
ZIP: 2200
BUSINESS PHONE: 4570702980
MAIL ADDRESS:
STREET 1: OLE MAALOES VEH 3
CITY: COPENHAGEN
STATE: G7
ZIP: 2200
4
1
form4.xml
X0508
4
2024-06-06
0001865494
IO Biotech, Inc.
IOBT
0001701247
Collins Helen Louise
C/O IO BIOTECH, INC.
OLE MAALOES VEJ 3
COPENHAGEN
G7
2200
DENMARK
true
false
Stock Option (Right to Buy)
1.25
2024-06-06
4
A
0
45642
0
A
2034-06-06
Common Stock
45642
45642
D
These options vest on June 6, 2025, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.
/s/ Brian Burkavage, Attorney-in-Fact for Helen Louise Collins
2024-06-07